About Accuray
Accuray is a company based in Sunnyvale (United States) founded in 1990. Accuray has raised $1.4 million across 5 funding rounds from investors including HHS. The company has 990 employees as of June 30, 2025. Accuray has completed 1 acquisition, including TomoTherapy. Accuray offers products and services including CyberKnife S7 and Radixact. Accuray operates in a competitive market with competitors including Brainlab, PROCEPT BioRobotics, Auris Health, Intuitive and Medical Microinstruments, among others.
- Headquarter Sunnyvale, United States
- Employees 990 as on 30 Jun, 2025
- Stage Public
-
Sectors
HealthcareIndustrial Goods & Manufacturing
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Accuray Incorporated
-
Annual Revenue
$458.5 M (USD)2.68as on Jun 30, 2025
-
Net Profit
-$1.59 M (USD)89.77as on Jun 30, 2025
-
EBITDA
$13.99 M (USD)55.28as on Jun 30, 2025
-
Total Equity Funding
$1.4 M (USD)
in 5 rounds
-
Latest Funding Round
$85 M (USD), Post-IPO
Jul 01, 2017
- Investors
-
Employee Count
990
as on Jun 30, 2025
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Accuray
Accuray is a publicly listed company on the NASDAQ with ticker symbol ARAY in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Accuray
Accuray offers a comprehensive portfolio of products and services, including CyberKnife S7 and Radixact.
Robotic device for precise stereotactic radiosurgery and body radiation therapy
Platform for image-guided intensity-modulated radiation therapy
People of Accuray
Unlock access to complete
Software Development Team
38 people
Leadership Team
28 people
Product Management Team
18 people
Sales and Marketing
15 people
Human Resources and Administration
13 people
Legal and Compliance
10 people
Senior Team
8 people
Finance and Accounting
8 people
Unlock access to complete
Funding Insights of Accuray
Accuray has successfully raised a total of $1.4M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $85 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Accuray
Accuray has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Accuray
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accuray
Accuray has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include TomoTherapy.
Investment portfolio details for Accuray
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Radiation therapy systems for treating various cancers are developed.
|
Locked | Locked | 1997 | Locked |
Complete acquisition details for Accuray
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Accuray
Detailed financials for Accuray
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accuray Comparisons
Peer comparison for Accuray
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accuray
Accuray operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brainlab, PROCEPT BioRobotics, Auris Health, Intuitive and Medical Microinstruments, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Software and integrated solutions for surgical and radiotherapy applications
|
|
| Locked | Locked | Locked |
Robotic waterjet system for prostate tissue removal is developed.
|
|
| Locked | Locked | Locked |
Robotic microsurgical systems for endoscopy are developed.
|
|
| Locked | Locked | Locked |
Robotic-assisted surgical systems are developed for minimally invasive procedures.
|
|
| Locked | Locked | Locked |
A robotic platform is used for microsurgery with scaled instruments.
|
|
| Locked | Locked | Locked |
Robotic laparoscopic systems are developed for minimally invasive surgeries.
|
Detailed competitors of Accuray
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accuray
Complete news archive for Accuray
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accuray
Accuray was founded in 1990 and raised its 1st funding round 15 years after it was founded.
Accuray is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Accuray is a funded company, having raised a total of $1.4M across 5 funding rounds to date.
As of Jun 30, 2025, the latest employee count at Accuray is 990.
Annual revenue of Accuray is $458.5M as on Jun 30, 2025.
Accuray was founded in 1990 and is headquartered in Sunnyvale, United States. Operations focus on the medical technology sector, where AI-based robotic radiosurgery systems are developed for planning, delivery, and data management in cancer treatments. Radiotherapy systems are also provided for alternative oncology applications. Services support clinical workflows in radiation therapy across global healthcare settings.
Accuray's top competitors include Brainlab, PROCEPT BioRobotics and Auris Health.
Accuray offers CyberKnife S7 and Radixact.
Yes, Accuray is publicly traded on NASDAQ under the ticker symbol ARAY.
Accuray has made 1 acquisition, including TomoTherapy.
Accuray has 1 investor. Key investors include HHS.
The ticker symbol of Accuray is ARAY on NASDAQ.